VistaPharm, FDA Monday, March 16, 2020 0.00 Neutral

FDA Approves METHADONE HYDROCHLORIDE — VistaPharm, LLC

VistaPharm, LLC announced the FDA approval of its methadone hydrochloride oral solution, effectively adding a new competitor to the market for a controlled substance that has historically faced significant supply shortages. This entry allows increased manufacturing capacity and competition, potentially stabilizing pricing and improving patient access to this essential pain management medication.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day